Revolution Medicines logo

Executive Director, Internal Audit, Technology and AI Audit

Revolution Medicines

Any City, USRemotePosted 1 day ago$252,000 - $315,000/year
Full TimeDirector & AboveCorporate FunctionsBiotechnology
Original posting ↗

Summary

The Executive Director, Internal Audit - Technology and AI will serve as a founding member of the Internal Audit leadership team responsible for managing independent assurance and advisory work that helps a rapidly growing global biotechnology company execute its strategy, scale its operations and deliver medicines to patients. The role reports to the Vice President of Internal Audit.

Job description

The Opportunity

The Executive Director, Internal Audit - Technology and AI will serve as a founding member of the Internal Audit leadership team responsible for managing independent assurance and advisory work that helps a rapidly growing global biotechnology company execute its strategy, scale its operations and deliver medicines to patients. The role reports to the Vice President of Internal Audit.

Responsibilities

  • Manage strategy, goals and methods for technology and AI audits while ensuring effective integration at business process levels. Assess dependencies across cybersecurity, cloud, identity, data, applications and third parties while ensuring adequate coverage with specialist assurance teams.
  • Develop and maintain a risk-based technology and AI audit portfolio aligned with business strategy, enterprise risks, major transformations, and the company's growth and global expansion.
  • Assess technology governance and control practices across areas such as cybersecurity, privacy, data governance, system development and change, resilience, and third-party risk.
  • Lead audits from scoping through reporting and follow-up, including clear conclusions, practical recommendations, and validation that agreed actions address the underlying risk.
  • Deliver assurance over the AI Lifecycle including inventory and risk classification, data sourcing, model evaluation, deployment governance, human oversight, third-party dependencies, change control, ongoing performance and retirement.
  • Lead strategic change in audit technology and AI methods to expand coverage and deliver timely assurance.
  • Assess management monitoring and run recurring independent tests.
  • Support Audit Committee reporting through the Internal Audit VP.

Leadership and Capabilities

  • Business Acumen, Trusted Advisor and Relationship Builder: Partner consistently with company leaders to influence strategy, governance and policy through independent, relevant insight.
  • Hands-On Execution: Willingness to execute granular testing and draft documentation directly as the team scales and adapts technology.

Requirements

  • 15+ years of progressive experience across technology assurance, operations and management
  • At least 5 years managing complex portfolios in the pharmaceutical or biotechnology spaces
  • Strong command of independent assurance, risk assessment, evidence evaluation, and technical testing beyond reliance solely on framework checklists
  • Experience with global expansion, enterprise changes and technology transformations
  • Demonstrated ability to assess strategic execution and operating effectiveness beyond general technology controls while partnering with leadership on negotiation of critical matters and influence on policy
  • Working knowledge of generative AI, retrieval-augmented generation, and agentic workflows, including access boundaries, tool use, untrusted inputs, evaluation design, and model or vendor changes

Benefits

  • Competitive Cash Compensation
  • Equity Awards
  • Learning & Development Opportunities
  • Strong Benefits

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.